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INTRODUCTION
Herpes simplex virus type 2 (HSV-2) can be transmitted
without any symptoms during the viral revital period through
genital mucus membrane by sexual contact. It can also be trans-
mitted vertically from an infected mother to the fetus (1-4).
Once infected, it is impossible to cure completely: it is hidden
in the neural system and revitalized with the weakening of
immune system or by a stimulus such as UVs to secrete infec-
tious HSV-2 (5, 6). Most of infected persons do not know infor-
mation about the transmission mode or the fact that contin-
uing sexual contacts could trigger transmission of HSV-2, even-
tually increasing the cumulative number of infected persons
(3, 7). Sexually transmitted infections (STIs) should be reported
to the related authority in Korea within 7 days when verified
by public health centers or clinics of any kind. STIs can be
classified according to its cause or the type of infected bacte-
ria and virus: syphilis, gonorrhea, chlamydia, non-gonococcal
urethritis, condyloma acuminata, and genital herpes. Although
HSV-2 infection is detected, it is not required to report its
occurrence to health authorities in most countries, so that it
is difficult to figure out the magnitude of its incidence. Korea
designated HSV-2 as a surveillance factor concerning commu-
nicable diseases in 2001. Each year 600-700 HSV-2 infected
persons or pseudo-infected persons are reported but informa-
tion on the magnitude of infection and the transmission rate
is insufficient (8). Since HSV-2 infection itself is not fatal, pre-
vention and treatment can be neglected, which increases the
risk of other STIs and the possibility of its transition to other
fatal diseases. For human papilloma virus (HPV)-infected
women with HSV-2, the incidence rate of cervical cancer is
2 to 3 times higher than that of women infected with HPV
only. Furthermore, it is reported that ulcer incurrence by
HSV-2 increases human immunodeficiency virus (HIV) infec-
tion rate by 3 to 9 times (9-11). The aims of this study were
to investigate the magnitude in HSV-2 infection in the gen-
eral public in Korea and to compare it with the magnitude
of infection of risk groups for STIs.
MATERIALS AND METHODS
In 2004, we selected 1,768 persons from the public health
centers in the region P, a big harbor city, and 882 in the re-
gion J, an inner rural area, both of which are located in the
southern part of Korea and conducted HSV-2 IgG antibody
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Herpes Simplex Virus Type 2 Seroprevalence in Korea: Rapid Increase
of HSV-2 Seroprevalence in the 30s in the Southern Part
To determine the characteristics of seroprevalence of herpes simplex virus type
2 (HSV-2) infection among Korean people, a cross-sectional study was conduct-
ed on three groups in 2004. The three groups consisted of the general public who
visited public health centers, commercial sex workers (CSWs), and human immu-
nodeficiency virus (HIV)-infected persons. Among the general public, HSV-2 sero-
prevalence rates for age under the 20s, in the 20s, 30s, 40s and the above 22.6%,
32.7% and 32.3%, respectively, which showed rapid increase of the rate in the 30s
(p<0.0001). In case of the above of 19 yr old, women (28.0%) was higher than men
(21.7%) (p<0.0001). The rate of CSWs (81.6%) was about 10 times higher than
that of general women. In case of HIV-infected men (47.6%), the figure was about
2-3 times higher than that of general men. The low rate in the teens and the 20s
proved that it is essential to develop sexually transmitted infections (STIs) preven-
tion programs of education and publicity for them as a precaution measure. This
study is the first major study of its kind on HSV-2 and would provide basic data for
prevention of STIs including information about target groups subject to vaccination
program.
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test for physical examination. All of them were visitors to pubic
health centers. 
In order to verify whether the seroprevalence data of the
southern part in Korea represents generality, we used the
stratified random sampling to select 455 sera from 40,000
samples obtained by the project of ‘‘National Survey of Health
and Nutrition (NSHN)’’ conducted between 6 April 2005
and 30 June 2005. The NSHN was a nationwide big pro-
ject to analyze the state of health and nutrition on a regular
basis under the supervision of the Ministry of Health and
Welfare in Korea. The 455 samples’ power was 80%. 
We also investigated 304 commercial sex workers (CSWs),
a high-risk group of STIs, who were to make regular visits to
health centers in two big cities, S and P, for a periodical STIs
examination. Furthermore, we examined HSV-2 seropreva-
lence in 196 persons infected with HIV by sexual contact in
2003.
Blood samples were processed by centrifugation at the site
of collection. The separated serum was aliquotted and then
frozen at -20℃. We used sera for IgG antibody test. To ex-
amine a HSV-2 specific antibody, HerpeSelect 2 ELISA IgG
(Focus Technologies, Memphis, TN, U.S.A.) was used accord-
ing to the manufacturer’s instructions.
We processed the data with Excel and used the Statistical
Analysis System for Windows (Ver. 8.1, SAS institute Inc., Cary,
NC, U.S.A.). The seroprevalence of the study group was defined
as the number of positive persons per one of the tested persons.
2 test was used to assess the difference of seroprevalence by
age, sex, and region. A p value less than 0.05 was considered
statistically significant. Power was checked for selecting sam-
ples from the National Survey of Health and Nutrition. The
stratified random sample selection by age and sex was used
for sampling the general public who represented the Korean
population.
RESULTS
Demographic characteristics for study groups are shown in
Table 1. Serological test results in child and youth in the region
P are in the Table 2, which indicates that the seroprevalence of
HSV-2 under the 20s was 2.8% (2.7% for men, 3.0% for
women), rendering no difference in seroprevalence for age (p=
0.4979) or for sex (p=0.7056). Table 3 shows that the seropreva-
lence of adults aged 20 and above was 24.9% and women
(28.0%) were recorded higher than men (21.7%) (p=0.0053);
7.4% for aged 20-29 (men 6.8% and women 8.0%, p=0.6817),
22.6% for aged 30-39 (men 13.8% and women 30.9%, p=
0.0004), 29.6-34.9% for aged 40 and above. Overall, the sero-
prevalence in the 30s (22.6%) significantly increased compared
with that of the 20s (7.4%) (p<0.0001), and in the 40s (32.7%)
than the 30s (p=0.0066), respectively. Women’s seroprevalence
greatly increased in the 30s (30.9%) than in the 20s (8.0%)
(p<0.001), while men’s increasing rate of seroprevalence in
the 20s (6.8%) compared to the 30s (13.8%) and the 30s to
the 40s (31.0%) was significantly higher in the older groups
(p=0.0497 and p=0.0005, respectively). Women’s seropreva-
lence was higher than that of men in the 30s, while the other
age groups showed no difference among the groups or gender
(p=0.0004). The comparison by region showed a contradic-
tory difference in the 20s and the 60s (p=0.0012, p=0.0209),
*, 196 HIV infected persons and 202 CSWs from S including 455 sera
from the National Survey of Health and Nutrition, 2005; 
� , 2,650 residents
in the region P and J including 455 sera from the National Survey of
Health and Nutrition, 2005. CSWs, commercial sex workers; HIV, human
immunodeficiency virus.
Characteristics No. tested %
Total 3,605
Gender 
Men 1,719 47.7
Women 1,886 52.3
Age
<20 1,301 36.1
20-29 841 23.3
30-39 540 15
40-49 353 9.8
50-59 291 8.1
≥60 279 7.7
Region 
P 1,870 51.9
J 882 24.4
Others* 853 23.7
Group
General
� 3,105 86.1
CSWs 304 8.5
The HIV infected 196 5.4
Table 1. Demographic characteristics of study groups
Age
Men
No. tested
(Positive)
% Positive
(95% CI)
Women
No. tested
(Positive)
% Positive
(95% CI)
Total
No. tested
(Positive)
% Positive
(95% CI)
≤6 198 (4) 2.0 (0.1-4.0) 199 (8) 4.0 (1.3-6.7) 397 (12) 3.0 (1.3-4.7)
7-12 200 (6) 3.0 (0.6-5.4) 198 (7) 3.5 (1.0-6.1) 398 (13) 3.3 (1.5-5.0)
13-19 202 (6) 3.0 (0.6-5.3) 197 (3) 1.5 (0.0-3.2) 399 (9) 2.3 (0.8-3.7)
Total 600 (16) 2.7 (0.1-4.0) 594 (18) 3.0 (1.7-4.4) 1,194 (34) 2.8 (1.9-3.8)
Table 2. HSV-2 seroprevalence of the general public (<20 yr old) in the region P of Korea
HSV-2, herpes simplex virus type 2; CI, confidence interval.HSV-2 Seroprevalence in Korea 959
but there was no difference after adjusted by age. Seropreva-
lence of in the 20s and above was not significant by region
under the standardized age (p=0.3949).
We selected samples from the national pool to verify whether
the age-specific HSV-2 seroprevalence of sexually active age
group in the southern part of Korea represents generality. The
HSV-2 seroprevalence among 455 adults aged between 10 and
35 in the NSHN was 8.8%; 4.7% for aged 10-19, 7.5% for
aged 20-24, 12.9% for aged 25-29, and 9.8% for aged 30-34.
There was no significant difference among age groups (p=
0.1681). The women’s seroprevalence was 12.7% and showed
a significant difference compared with the seroprevalence in
men, 4.8% (Table 4, p<0.0001).
As shown in Table 5, the seroprevalence of HSV-2 in Kore-
an CSWs was 81.6%, which was remarkably different with
those of the 20s (8.0%) and the 30s (30.9%) in the general
public of the southern part of Korea (p=0.0054). The seropreva-
lence of HIV-infected Koreans was 48.5%. The age-specific
HSV-2 seroprevalence of HIV-infected men was 23.9% for the
20s, 48.6% for the 30s, 57.1% for the 40s and 69.2% for the
50s, respectively, showing an increasing trend by age (p<
0.0001). The seroprevalence of the HIV infected women
(63.6%) was higher than that of the infected men (47.6%).
Due to the unbalance between the sexes, there was no differ-
ence after stratified by sex (p=0.3002). In the seroprevalence of
women of age 20-39, CSWs (81.6%) were recorded remark-
ably higher than the general women of the southern part
(18.5%) (p<0.0001). Fig. 1 shows that the seroprevalence of
186 HIV-infected men (47.3%) was also significantly high-
er than that of the general men in the southern part (21.7%)
(p<0.0001).
DISCUSSION
This is the first voluminous study in Korea which inves-
Age Sex
Region P
No. tested
(Positive)
% Positive
(95% CI)
Region J
No. tested
(Positive)
% Positive
(95% CI)
Total
No. tested
(Positive)
% Positive
(95% CI)
20-29 M 100 (2) 2.0 (0.0-4.7) 48 (8) 16.7 (6.1-27.2) 148 (10) 6.8 (2.7-10.8)
F 118 (7) 5.9 (1.7-10.2) 58 (7) 12.1 (3.7-20.5) 176 (14) 8.0 (4.0-12.0)
Subtotal 218 (9) 4.1 (1.5-6.8) 106 (15) 14.2 (7.5-20.8) 324 (24) 7.4 (4.6-10.3)
30-39 M 53 (10) 18.9 (8.3-29.4) 85 (9) 10.6 (4.0-17.1) 138 (19) 13.8 (8.0-19.5)
F 52 (15) 28.8 (16.5-41.2) 97 (31) 32.0 (22.7-41.2) 149 (46) 30.9 (23.5-38.3)
Subtotal 105 (25) 23.8 (15.7-32.0) 182 (40) 22.0 (16.0-28.0) 287 (65) 22.6 (17.8-27.5)
40-49 M 56 (15) 26.8 (15.2-38.4) 99 (33) 33.3 (24.0-42.6) 155 (48) 31.0 (23.7-38.2)
F 49 (15) 30.6 (17.7-43.5) 99 (36) 36.4 (26.9-45.8) 148 (51) 34.5 (26.8-42.1)
Subtotal 105 (30) 28.6 (19.9-37.2) 198 (69) 34.8 (28.2-41.5) 303 (99) 32.7 (27.4-38.0)
50-59 M 34 (11) 32.4 (16.6-48.1) 100 (31) 31.0 (21.9-40.1) 134 (42) 31.3 (23.5-39.2)
F 40 (18) 45.0 (29.6-60.4) 98 (35) 35.7 (26.2-45.2) 138 (53) 38.4 (30.3-46.5)
Subtotal 74 (29) 39.2 (28.1-50.3) 198 (66) 33.3 (26.8-39.9) 272 (95) 34.9 (29.3-40.6)
≥60 M 32 (12) 37.5 (20.7-54.3) 99 (22) 22.2 (14.0-30.4) 131 (34) 26.0 (18.4-33.5)
F 40 (17) 42.5 (27.2-57.8) 99 (29) 29.3 (20.3-31.3) 139 (46) 33.1 (25.3-40.9)
Subtotal 72 (29) 40.3 (28.9-51.6) 198 (51) 25.8 (19.7-31.8) 270 (80) 29.6 (24.2-35.1)
Total M 275 (50) 18.2 (13.6-22.7) 431 (103) 23.9 (19.9-27.9) 706 (153) 21.7 (18.6-24.7)
F 299 (72) 24.1 (19.2-28.9) 451 (138) 30.6 (26.3-34.9) 750 (210) 28.0 (24.8-31.2)
Total 574 (122) 21.3 (17.9-24.6) 882 (241) 27.3 (24.4-30.3) 1,456 (363) 24.9 (22.7-27.2)
Table 3. HSV-2 seroprevalence of the general public (≥20 yr old) who visited public health centers in the southern part of Korea in
2004
HSV-2, herpes simplex virus type-2; CI, confidence interval; M, male; F, female.
Age
Men
No. tested
(Positive)
% Positive
(95% CI)
Women
No. tested
(Positive)
% Positive
(95% CI)
Total
No. tested
(Positive)
% Positive
(95% CI)
10-19 57 (2) 3.5 (2.6-4.5)  50 (3) 6.0 (0.0-12.6) 107 (5) 4.7 (0.7-8.7)
20-24 59 (1) 1.7 (0.0-5.0) 61 (8) 13.1 (4.6-21.6) 120 (9) 7.5 (2.8-12.2)
25-29 57 (4) 7.0 (0.4-13.6) 59 (11) 18.6 (8.7-28.6) 116 (15) 12.9 (6.8-19.0)
30-34 54 (4) 7.4 (0.4-14.4) 58 (7) 12.1 (10.4-13.7) 112 (11) 9.8 (4.3-15.3)
Total 227 (11) 4.8 (2.1-7.6) 228 (29) 12.7 (8.4-17.0) 455 (40) 8.8 (6.2-11.4)
Table 4. HSV-2 seroprevalence rate of the general public from the National Survey of Health and Nutrition in Korea in 2005
HSV-2, herpes simplex virus type-2; CI, confidence interval.960 H.S. Shin, J.J. Park, C. Chu, et al.
tigated the seroprevalence of HSV-2 in age close to being sex-
ually active or in its peak in the two groups, CSWs and HIV-
infected persons. In a group of the general public in Korea, the
seroprevalence of the 1,855 subjects aged 13 and above in the
southern part was 20.1% (20.9% for men, 22.4% for women),
similar to that of the United States (12). In the United States,
the seroprevalence of age 12 and above in the general public
was 21.9%, 17.8% for men and 25.6% for women (12). How-
ever, Korea’s seroprevalence for the aged 13-19 (2.3%) show-
ed a significant difference with that of the United States (5.6
%) and even it was lowered than 4.5% among white people
in the United States. The age-specific seroprevalence of HSV-
2 in the United States was 17.2% for the 20s, 27.8% for the
30s, 26.6% for the 40s, 25.1% for the 50s, and 24.3% for
the 60s. As shown above the 20s, the seroprevalence of age
20-30 in Korea was lower than that of the same ages in the
United States, but in the 40s and above in Korea showed a
higher seroprevalence compared with the counterpart in the
United States (7, 12). The seroprevalence of Koreans under
the 20s was 2.8%, which was similar to that of Bangladesh
(age 1-12, 2.5%) and that of the United Kingdom (16-19,
2-3%) (13, 14). 
The HSV-2 seroprevalence of women in the 20s in the south-
ern part of Korea was 8.0%, while that of the 30s was sharply
increasing to 30.9%, which consolidated the importance of
a STI prevention program. Considering the average age of the
first marriage is 27 in Korea, the HSV-2 seroprevalence in the
30s can be an important indicator to trace vertical transmission
as women are likely give birth to their first babies in their 20s
or 30s (15). It was reported that the HSV-2 seroprevalence of
pregnant women in the United States was 32% and transmis-
sion rate of birth infected by primary HSV was 30-50%, and
recurred HSV was 1-4% (12). The prevalence of herpes infec-
tion for newborn babies was less than 10 per 100,000 per-
sons in Europe, 15-48 in the United States, and more than
85% of the infection’s pathogen was HSV-2.
Age-specific HSV-2 seroprevalence in the general public in
Korea showed that the seroprevalence of people under the 20
was the lowest, less than 5%, despite their sexual experience
rate of 7.1-31.7% in age 13-19 according to the juvenile
sexual activity study, which was lower than that of the group
under 13 (16). This contradiction necessitated the further
study on the relation between HSV-2 seroprevalence and sex-
ual activity. Regardless of the fact that people in the 20s are
sexually active and have sexual experience (57.3%), it was
found that HSV-2 seroprevalence was very low. However,
the regional difference between region P and J was reported
to be substantial (17, 18).
We aimed at understanding the nationwide state of age-spe-
cific HSV-2 infection notwithstanding the limited sampling
region in this study, so we conducted an investigation on the
HSV-2 seroprevalence of 455 sera from the NHSN as a pilot
study for generalization of HSV-2 seroprevalence in Korea. We
still found a low seroprevalence rate of 4.7% for age 10-19,
7.5% for 20-24, 12.9% for 25-29, and 9.8% for 30-34. How-
ever, in age 30-34, the HSV-2 prevalence of NHSN was rather
lower than that of subjects of the southern part. We intend-
ed to observe a dynamic change by age and to compare data
collected from the southern part of Korea as a seroprevalence
study on sera from the National Survey of Health and Nutri-
tion, but there was no difference in the 20s and in the early
30s. Since a different pattern in the southern part has known,
it is necessary to study HSV-2 seroprevalence in Korea to cover
more regions with a bigger sample size.
Lee et al. conducted a study for university students (age 18-
25) in 2005 and showed the prevalence rate of Chlamhydia
trachomatis was 8.4% for men, 10.6% for women, and that
Age
HIV-infected persons CSWs
Men
No. tested
(Positive)
No. tested 
(Positive)
% Positive
(95% CI) % Positive 
(95% CI)
Total
No. tested
(Positive)
% Positive 
(95% CI)
Women
No. tested
(Positive)
% Positive 
(95% CI)
20-29 234 (183) 78.2 (72.9-83.5) 46 (11) 23.9 (11.6-36.2) 1 (1) 100 (100-100) 47 (12) 25.5 (13.1-38.0)
30-39 65 (60) 92.3 (85.8-98.8) 72 (35) 48.6 (37.1-60.2) 4 (2) 50 (1.0-99.0) 76 (37) 48.7 (37.4-51.9)
40-49 5 (5) 100 (100-100) 42 (24) 57.1 (42.2-72.1) 3 (2) 66.7 (13.3-120) 45 (26) 57.8 (43.3-72.2)
≥50 - - 26 (18) 69.2 (51.5-87.0) 2 (2) 100 (100-100) 28 (20) 71.4 (54.7-88.2)
Total 304 (248) 81.6 (77.2-85.9) 185 (88) 47.6 (40.1-54.5) 11 (7) 63.6 (41.6-98.4) 196 (95) 48.5 (41.5-55.5)
Table 5. HSV-2 seroprevalence of CSWs and HIV-infected persons in Korea
HSV-2, herpes simplex virus type-2; CI, confidence interval; HIV, human immunodeficiency virus; CSWs, commercial sex workers.
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Fig. 1. Comparison of age-specific HSV-2 seroprevalence rates in
four groups.of Neisseria gonorrhea was 0.8% for men and 0.0% women.
These figures were lower than those of the Australian coun-
terparts; 16.4% and 4.9% for subjected age 20-24, 18.2%
and 5.5% for subjected age 30-34 (19, 20).
In this study, the HSV-2 seroprevalence in women was higher
than in men, and that the HSV-2 prevalence rate of women in
the 30s was four times higher than in the 20s. This fact could
be verified the necessity of intensive STIs prevention programs
and publicity to target people in the 20s in order to reduce the
current 30-40% rate. Furthermore, the seroprevalence of
HSV-2 of CSWs, a high-risk group of STIs, was much higher
than that of the general public. Since the high seroprevalence
of CSWs could accelerate transmission of sexually-transmit-
ted virus such as HIV, it is necessary to launch education pro-
grams to prevent any transmission of STIs. The seropreva-
lence of CSWs in Japan, Germany, and Thailand ranges bet-
weens 60% and 80% (21-23). The figure similar to Korean
CSWs’ 81.6%. Blood testing is encouraged to people sus-
pected of HSV-2 infection, even though they have no symp-
toms. People are also persuaded to use condom for precau-
tion and safety.
The HSV-2 seroprevalence of HIV infected persons was lower
than that of CSWs, but much higher than the general public.
The seroprevalence of HSV-2 in HIV-infected Brazilians was
73%, which was higher than that of Koreans, 48.5% (24). It
was reported that ulcerous STIs such as HSV could increase
HIV infection rate by 3 to 9 times (20). Therefore, preven-
tion of HSV-2 infection is related to the prevention of HIV
infection. According to the Fisman’s study, without interven-
tion, the prevalence of HSV-2 infection among individuals
aged 15 to 39 in the United States was projected to increase up
to 39% among men and 49% among women by 2025. In
addition, the annual cost of new infections could be risen
from $1.8 billion in 2000 to $2.7 billion in 2025 (25). Kore-
ans currently have run short of the medical expenses for HSV-
2 infection. The much lower seroprevalence rate of HSV-2
in teenagers and the 20s compared with the remarkably high
rate in the 30s showed that it is necessary to develop a STIs
prevention program of education and publicity for the 20s
as well as for teenagers. This study is the first report to inves-
tigate the magnitude of HSV-2 infection in the general pub-
lic as compared with a high-risk group (CSWs) and the HIV-
infected group for the advanced understanding of HSV-2
infection status. It provides basic data for consistent and sys-
tematic HSV-2 studies and information about the target
groups for STIs vaccine program.
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